REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medigen S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medigen S.A.S. Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Medigen S.A.S. is based in Colombia. The head office is in Cali. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on February 19, 2004. 1 (2024) employees currently work for Medigen S.A.S.. From the latest financial highlights, Medigen S.A.S. reported a net sales revenue increase of 18.13% in 2023. Its’ total assets recorded a growth of 80.13%. In 2023, Medigen S.A.S.’s net profit margin increased by 6.93%.

Headquarters
Cl 30 # 11 G - 46
Cali; Valle del Cauca;

Contact Details: Purchase the Medigen S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Medigen S.A.S. report to view the information.
Outstanding Shares:
Purchase the Medigen S.A.S. report to view the information.
Incorporation Date:
February 19, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Medigen S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
18.13%▲
Total operating revenue
22.43%▲
Operating profit (EBIT)
72.67%▲
EBITDA
1033.33%▲
Net Profit (Loss) for the Period
237.19%▲
Total assets
80.13%▲
Total equity
22.67%▲
Operating Profit Margin (ROS)
5.45%▲
Net Profit Margin
6.93%▲
Return on Equity (ROE)
10.23%▲
Debt to Equity Ratio
70.63%▲
Quick Ratio
1.19%▲
Cash Ratio
0.2%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo